FDA
-
-
-
-
-
-
-
New Retrospective Study Reports Significantly Reduced Post-Operative GERD Rates with the Titan SGS™ Stapler from Teleflex Compared with Multi-Fire Staplers in Sleeve Gastrectomy
-
-
-
-
-
-
-
Cagent Vascular Appoints Paul Wilson as Chief Commercial Officer to Drive Growth and Market Expansion
-
-
-
-
-
-
-
Outcomes From Two New Head-to-Head Randomized Controlled Trials Involving the UroLift™ System Highlight a Superior Patient Experience* Against Rezūm and Its Advantage Over Medical Therapy as an Ear
-
-
-
-
-
-
-
Teleflex (TFX) Granted FDA Clearance for Expanded Indication for QuikClot Control+ Hemostatic Device Usage
-
-
-
-
-
-
-
Teleflex (TFX) Receives FDA Clearance for the Wattson Temporary Pacing Guidewire
-
-
-
-
-
-
-
Teleflex Expands Interventional Cardiology Portfolio with Two New FDA-Cleared Catheter Devices for Use in Complex Percutaneous Coronary Interventions (PCI)
-
-
-
-
-
-
-
Published Data Demonstrate Consistent PUL Outcomes for the Treatment of Median Lobe Obstruction Across Controlled and Real-World Settings
-
327,802 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

